• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Dow Edges Lower; US Current Account Deficit Widens In Q1

    6/20/24 9:42:46 AM ET
    $GRDI
    $MBIO
    $MGOL
    $NLSP
    EDP Services
    Technology
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Get the next $GRDI alert in real time by email

    U.S. stocks traded mixed this morning, with the S&P 500 gaining around 0.1% on Thursday.

    Following the market opening Thursday, the Dow traded down 0.10% to 38,795.35 while the NASDAQ rose 0.16% to 17,890.82. The S&P 500 also rose, gaining, 0.12% to 5,493.76.

    Check This Out: Workday To Rally Over 52%? Here Are 10 Top Analyst Forecasts For Thursday

    Leading and Lagging Sectors

    Financial shares jumped by 0.6% on Thursday.

    In trading on Thursday, communication services shares fell by 0.8%.

    Top Headline

    The U.S. current account deficit rose by $15.8 billion to $237.6 billion during the first quarter, and versus market estimates of a $206.4 billion gap.

    Equities Trading UP
                           

    • MGO Global, Inc. (NASDAQ:MGOL) shares shot up 236% to $1.54 after the company said it expects the pending acquisition of Spetner Associates to close in the second half of 2024, projecting it to increase annualized revenue to approximately $28 million.
    • Shares of Griid Infrastructure Inc. (NASDAQ:GRDI) got a boost, surging 88% to $1.05 after falling more than 10% on Tuesday.
    • Reliance Global Group, Inc. (NASDAQ:RELI) shares were also up, gaining 77% to $0.69. Reliance Global Group announced major enhancement of capital structure following cashless exercise of warrants.

    Equities Trading DOWN

    • Mustang Bio, Inc. (NASDAQ:MBIO) shares dropped 26% to $0.6250 after the company announced a $2.5 million registered direct offering of 6.130 million shares at $0.41 per share.
    • Shares of NLS Pharmaceutics AG (NASDAQ:NLSP) were down 28% to $0.1940 after jumping 82% on Tuesday.
    • Sonnet BioTherapeutics Holdings, Inc. (NASDAQ:SONN) was down, falling 26% to $1.14. Sonnet BioTherapeutics announced exercise of warrants for gross proceeds of $3.4 million.

    Also Check This Out: Top 4 Financial Stocks That Could Lead To Your Biggest Gains In Q2

    Commodities

    In commodity news, oil traded up 0.1% to $81.63 while gold traded up 0.3% at $2,353.00.

    Silver traded up 2.5% to $30.305 on Thursday, while copper rose 0.4% to $4.5060.

    Euro zone

    European shares were higher today. The eurozone's STOXX 600 gained 0.5%, Germany's DAX rose 0.6% and France's CAC 40 gained 1.1%. Spain's IBEX 35 Index rose 0.5%, while London's FTSE 100 climbed 0.4%.

    The Bank of England held the Bank Rate at 5.25% during its recent meeting, as projected. Producer prices in Germany fell by 2.2% year-over-year in May compared to a 3.3% decline in the earlier month.

    Passenger car registrations in the European Union fell 3.0% year-over-year to a three-month low level of 911.7 thousand units in May.

    Asia Pacific Markets

    Asian markets closed mixed on Thursday, with Japan's Nikkei gaining 0.16%, Hong Kong's Hang Seng Index declining 0.52%, China's Shanghai Composite Index falling 0.42% and India's S&P BSE Sensex gaining 0.18%.

    The People’s Bank of China maintained key lending rates at the June fixing. Hong Kong's unemployment rate came in unchanged at 3% during the three months ending May. Singapore's unemployment rate increased to 2.1% in the first quarter of 2024 versus 2.0% in the prior period.

    Economics

    • The U.S. current account deficit rose by $15.8 billion to $237.6 billion during the first quarter, and versus market estimates of a $206.4 billion gap.
    • The Philadelphia Fed Manufacturing Index fell 3.2 points to a reading of 1.3 in June, missing market expectations of 5.
    • U.S. initial jobless claims fell by 5,000 to 238,000 in the second week of June, compared to market estimates of 235,000.
    • Housing starts in declined 5.5% to an annualized rate of 1.277 million in May, while building permits fell by 3.8% to an annual rate of 1.386 million.

    Now Read This: How To Earn $500 A Month From Smith & Wesson Brands Stock Ahead Of Q4 Earnings

    Get the next $GRDI alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $GRDI
    $MBIO
    $MGOL
    $NLSP

    CompanyDatePrice TargetRatingAnalyst
    Sonnet BioTherapeutics Holdings Inc.
    $SONN
    2/9/2022$5.00 → $2.00Buy
    BTIG
    Reliance Global Group Inc.
    $RELI
    2/2/2022$7.00Buy
    EF Hutton
    Mustang Bio Inc.
    $MBIO
    1/24/2022$13.00 → $6.00Buy
    B. Riley Securities
    Sonnet BioTherapeutics Holdings Inc.
    $SONN
    12/20/2021$8.00 → $2.50Buy
    Chardan Capital
    Sonnet BioTherapeutics Holdings Inc.
    $SONN
    12/16/2021$2.00Buy
    HC Wainwright & Co.
    Sonnet BioTherapeutics Holdings Inc.
    $SONN
    9/15/2021$5.00Buy
    BTIG
    More analyst ratings

    $GRDI
    $MBIO
    $MGOL
    $NLSP
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Reliance Global Group Enters Term Sheet to Acquire Controlling Stake in Enquantum, a Post-Quantum Cybersecurity Company

    LAKEWOOD, NJ, Jan. 26, 2026 (GLOBE NEWSWIRE) -- Reliance Global Group, Inc. (NASDAQ:EZRA) (the "Company") today announced that it has entered into a non-binding term sheet to acquire a controlling interest in Enquantum Ltd., a post-quantum cryptography technology company addressing what many experts view as an emerging and systemic threat to essential global services and digital infrastructure that rely on encryption for security. In addition, in connection with the term sheet, On January 15, 2026, Reliance executed a secured promissory note as an advance of the initial funding under a definitive agreement, if executed. The Promissory Note is secured by all of the assets of Enquantum and p

    1/26/26 9:00:00 AM ET
    $RELI
    Specialty Insurers
    Finance

    Reliance Global Group Announces NASDAQ Ticker Symbol Change from "RELI" to "EZRA" Following Recent Announcement of First Planned Acquisition Under EZRA International Group

    Company to Begin Trading Under New Symbol "EZRA" on January 26, 2026 Acquisition Strategy Offers Transformative Potential, Complementing Cash Flow Foundation of Insurance Holdings LAKEWOOD, NJ, Jan. 22, 2026 (GLOBE NEWSWIRE) -- Reliance Global Group, Inc. (NASDAQ:RELI) (the "Company") today announced that its ticker symbol on the NASDAQ Capital Market will change from "RELI" to "EZRA", effective at the open of trading on Monday, January 26, 2026. The Company's common stock will continue to be listed on NASDAQ, and its CUSIP number will remain unchanged. The ticker symbol change is intended to better reflect the Company's strategic evolution, including the formation of EZRA International

    1/22/26 9:45:00 AM ET
    $RELI
    Specialty Insurers
    Finance

    Reliance Global Group Signs Term Sheet to Acquire Majority Stake in Israeli AI Diagnostic Company, Scentech, Positioning for Entry into the Multi-Billion Dollar Early Disease Detection Market

    Transaction structured to achieve majority ownership through performance-based clinical and regulatory milestones Marks first strategic acquisition for new division—Ezra International Group Lakewood, NJ, Jan. 07, 2026 (GLOBE NEWSWIRE) -- Reliance Global Group, Inc. (NASDAQ:RELI) ("Reliance" or the "Company") today announced that it has entered into a non-binding term sheet ("the term sheet") to acquire a majority equity position of Scent Medical Technologies Ltd ("Scentech"). Scentech is a diagnostics company developing artificial intelligence technologies designed to identify disease-associated molecular signatures in human breath. Scentech's product candidates are under development and

    1/7/26 8:30:00 AM ET
    $RELI
    Specialty Insurers
    Finance

    $GRDI
    $MBIO
    $MGOL
    $NLSP
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    BTIG reiterated coverage on Sonnet BioTherapeutics with a new price target

    BTIG reiterated coverage of Sonnet BioTherapeutics with a rating of Buy and set a new price target of $2.00 from $5.00 previously

    2/9/22 6:54:44 AM ET
    $SONN
    Biotechnology: Pharmaceutical Preparations
    Health Care

    EF Hutton initiated coverage on Reliance Global Group with a new price target

    EF Hutton initiated coverage of Reliance Global Group with a rating of Buy and set a new price target of $7.00

    2/2/22 9:08:11 AM ET
    $RELI
    Specialty Insurers
    Finance

    B. Riley Securities reiterated coverage on Mustang Bio with a new price target

    B. Riley Securities reiterated coverage of Mustang Bio with a rating of Buy and set a new price target of $6.00 from $13.00 previously

    1/24/22 8:55:18 AM ET
    $MBIO
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $GRDI
    $MBIO
    $MGOL
    $NLSP
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Large owner Fortress Biotech, Inc. was granted 278,385 shares, increasing direct ownership by 108% to 536,577 units (SEC Form 4)

    4 - MUSTANG BIO, INC. (0001680048) (Issuer)

    1/5/26 4:30:31 PM ET
    $MBIO
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Director Herskowitz Neil sold $238 worth of shares (247 units at $0.96), decreasing direct ownership by 63% to 145 units (SEC Form 4)

    4 - MUSTANG BIO, INC. (0001680048) (Issuer)

    12/30/25 4:17:34 PM ET
    $MBIO
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Director Chill Adam J. sold $4 worth of shares (4 units at $0.95), decreasing direct ownership by 1% to 375 units (SEC Form 4)

    4 - MUSTANG BIO, INC. (0001680048) (Issuer)

    12/30/25 4:16:14 PM ET
    $MBIO
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $GRDI
    $MBIO
    $MGOL
    $NLSP
    SEC Filings

    View All

    SEC Form 424B4 filed by Reliance Global Group Inc.

    424B4 - Reliance Global Group, Inc. (0001812727) (Filer)

    1/29/26 10:02:21 AM ET
    $RELI
    Specialty Insurers
    Finance

    SEC Form EFFECT filed by Reliance Global Group Inc.

    EFFECT - Reliance Global Group, Inc. (0001812727) (Filer)

    1/29/26 12:15:25 AM ET
    $RELI
    Specialty Insurers
    Finance

    SEC Form S-1 filed by Reliance Global Group Inc.

    S-1 - Reliance Global Group, Inc. (0001812727) (Filer)

    1/23/26 8:42:08 AM ET
    $RELI
    Specialty Insurers
    Finance

    $GRDI
    $MBIO
    $MGOL
    $NLSP
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Jin David bought $238 worth of shares (247 units at $0.96), increasing direct ownership by 633% to 286 units (SEC Form 4)

    4 - MUSTANG BIO, INC. (0001680048) (Issuer)

    12/30/25 4:15:14 PM ET
    $MBIO
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Chairman and CEO Beyman Ezra was granted 249,000 shares, covered exercise/tax liability with 55,787 shares and bought $8,502 worth of shares (30,000 units at $0.28), increasing direct ownership by 73% to 527,100 units (SEC Form 4)

    4 - Reliance Global Group, Inc. (0001812727) (Issuer)

    6/28/24 6:10:12 AM ET
    $RELI
    Specialty Insurers
    Finance

    Amendment: Chairman and CEO Beyman Ezra disposed of 289,277 shares, acquired $43,003 worth of shares (356,020 units at $0.12), was granted 168,000 shares, covered exercise/tax liability with 88,382 shares, bought $50,220 worth of shares (186,000 units at $0.27) and gifted 96,667 shares, increasing direct ownership by 694% to 303,886 units (SEC Form 4)

    4/A - Reliance Global Group, Inc. (0001812727) (Issuer)

    6/28/24 6:06:37 AM ET
    $RELI
    Specialty Insurers
    Finance

    $GRDI
    $MBIO
    $MGOL
    $NLSP
    Financials

    Live finance-specific insights

    View All

    Reliance Global Group (RELI) Adds to Zcash (ZEC) Position, and Continues Implementing Its Institutional ZEC Adoption Strategy

    LAKEWOOD, NJ, Dec. 08, 2025 (GLOBE NEWSWIRE) -- Reliance Global Group, Inc. (NASDAQ:RELI) ("Reliance", "we" or the "Company") today announced that it has deployed additional cash to increase its Zcash (ZEC) position. This additional allocation to the Company's Digital Asset Treasury ("DAT") reflects the Company's internal view that ZEC may be an institutionally adaptable and technologically resilient privacy-enabled digital asset and may play a meaningful role in its long-term treasury strategy. Zcash's dual architecture which combines transparent auditability with optional privacy in the Company's view supports its appeal to organizations seeking digital assets that can be implemented fo

    12/8/25 2:40:00 PM ET
    $RELI
    Specialty Insurers
    Finance

    Reliance Global Group Increases Zcash (ZEC) Position Through Additional Cash Deployment

    LAKEWOOD, NJ, Nov. 26, 2025 (GLOBE NEWSWIRE) -- Reliance Global Group, Inc. (NASDAQ:RELI) ("Reliance", "we" or the "Company") today announced that it has deployed additional cash into its Zcash (ZEC) position, as part of its focused Digital Asset Treasury ("DAT") strategy. This step follows Reliance's recent consolidation of its digital asset holdings into Zcash and reflects the Company's current view of ZEC as its primary digital asset exposure within that strategy. Zcash's architecture, featuring a Bitcoin-based security model enhanced with optional privacy and selective disclosure, continues to distinguish it from other blockchain networks. Its dual-transaction model provides transpare

    11/26/25 9:30:00 AM ET
    $RELI
    Specialty Insurers
    Finance

    Reliance Global Group (RELI) Consolidates Digital Asset Treasury Into Zcash (ZEC)

    LAKEWOOD, NJ, Nov. 25, 2025 (GLOBE NEWSWIRE) -- Reliance Global Group, Inc. (NASDAQ:RELI) ("Reliance", "we" or the "Company") today announced that it has completed a strategic realignment of its Digital Asset Treasury ("DAT"), by consolidating its digital asset position into Zcash (ZEC). The Company has fully exited its prior holdings and reallocated the proceeds into Zcash, a leading privacy-preserving cryptocurrency built on Bitcoin's foundational architecture. This decision follows a comprehensive strategic review in which the Company along with Blake Janover, the Chaiman of the Crypto Advisory Board determined, after an in-depth assessment, that Zcash presented the most compelling opp

    11/25/25 8:30:00 AM ET
    $RELI
    Specialty Insurers
    Finance

    $GRDI
    $MBIO
    $MGOL
    $NLSP
    Leadership Updates

    Live Leadership Updates

    View All

    NewcelX Strengthens Scientific Advisory Board with Appointment of Jeremy Shefner, MD, PhD, Chief Medical Officer at the Barrow Neurological Institute

    ZURICH and NESS ZIONA, Israel, Nov. 17, 2025 /PRNewswire/ -- NewcelX Ltd. (NASDAQ:NCEL) ("NewcelX" or "the Company"), a clinical-stage biotechnology company developing cell-based and small-molecule therapies for neurodegenerative and metabolic diseases, today announced the appointment of Prof. Jeremy Shefner, MD, PhD, to the Company's Scientific Advisory Board ("SAB").   Prof. Shefner is a highly respected neurologist specializing in amyotrophic lateral sclerosis (ALS) and neuromuscular disorders. He serves as Professor of Neurology and Chief Medical Officer for Clinical Research at Barrow Neurological Institute in Phoenix, Arizona — an internationally recognized leader in the treatment and

    11/17/25 7:00:00 AM ET
    $NCEL
    $NLSP
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Sonnet Announces the Passing of Founder and CEO Pankaj Mohan, Ph.D.

    PRINCETON, N.J., April 01, 2025 (GLOBE NEWSWIRE) -- Sonnet BioTherapeutics Holdings, Inc. (NASDAQ:SONN) (the "Company" or "Sonnet"), a clinical-stage company developing immunotherapeutic drugs targeted to the tumor microenvironment (TME), today announced with deep and profound sadness the tragic passing of Pankaj Mohan, Ph.D., Sonnet Founder and Chief Executive Officer. The Company's Board of Directors has unanimously approved the appointment of current board member Raghu Rao, as Interim Chief Executive Officer of the Company, and the promotion of Stephen McAndrew, Ph.D., the Company's current Chief Business Officer, to President and Chief Business Officer of the Company. The Board intends

    4/1/25 7:30:00 AM ET
    $SONN
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Sonnet BioTherapeutics Appoints Stephen McAndrew, Ph.D. as Chief Business Officer

    PRINCETON, N.J., Feb. 13, 2025 (GLOBE NEWSWIRE) -- Sonnet BioTherapeutics Holdings, Inc. (NASDAQ:SONN) (the "Company" or "Sonnet"), a clinical-stage company developing targeted immunotherapeutic drugs, announced today the appointment of Stephen J. McAndrew, Ph.D., as Chief Business Officer, effective February 17, 2025. Dr. McAndrew brings more than 30 years of experience with various business models and types of transactional agreements involving biologics at different stages of development. During the course of his tenure at Sonnet, Dr. McAndrew has served as Vice President and then Senior Vice President, Business Development, and has been responsible for developing and leading the Compa

    2/13/25 8:30:00 AM ET
    $SONN
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $GRDI
    $MBIO
    $MGOL
    $NLSP
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by NLS Pharmaceutics Ltd.

    SC 13G/A - NLS Pharmaceutics Ltd. (0001783036) (Subject)

    11/21/24 4:01:13 PM ET
    $NLSP
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Amendment: SEC Form SC 13G/A filed by NLS Pharmaceutics Ltd.

    SC 13G/A - NLS Pharmaceutics Ltd. (0001783036) (Subject)

    11/14/24 7:27:23 PM ET
    $NLSP
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Amendment: SEC Form SC 13G/A filed by Reliance Global Group Inc.

    SC 13G/A - Reliance Global Group, Inc. (0001812727) (Subject)

    11/14/24 4:26:59 PM ET
    $RELI
    Specialty Insurers
    Finance